HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Did telehealth appointments improve HIV care retention during the COVID-19 pandemic?

In a new study, researchers assessed how measures of retention in human immunodeficiency virus (HIV) care have changed due to the COVID-19 pandemic.

6 Oct 2022

Gut microbiome could contribute to a person's risk for HIV infection, research suggests

New UCLA-led research suggests certain gut bacteria -- including one that is essential for a healthy gut microbiome – differ between people who go on to acquire HIV infection compared to those who have not become infected.

30 Sep 2022

Gut microbiome likely to contribute to HIV infection

30 Sep 2022

Court ruling may spur competitive health plans to bring back copays for preventive services

Tom and Mary Jo York are a health-conscious couple, going in for annual physicals and periodic colorectal cancer screening tests. Mary Jo, whose mother and aunts had breast cancer, also gets regular mammography tests.

15 Sep 2022

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Potential HIV vaccine component leads to strong protection in primates

To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses.

9 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

NIH experts discuss a published case series detailing the symptoms and outcomes of monkeypox

Lessons learned from the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health experts write in an editorial published today in the New England Journal of Medicine.

25 Aug 2022

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

The recent rise in sexually transmitted infections (STIs) in the United States foreshadowed the new monkeypox outbreak.

24 Aug 2022

A needle exchange project modeled on urban efforts aims to save lives in rural Nevada

Richard Cusolito believes he's saving lives by distributing clean syringes and needles to people who use drugs in this rural area of northeastern Nevada — but he knows some residents disagree.

24 Aug 2022

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Due to a lack of publicly available data, understanding what products medical cannabis patients use for various conditions has mostly come from survey responses.

22 Aug 2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

A clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the medications, but the rates of behavior change for alcohol consumption and smoking were high in all treatment groups. Results suggest these medications could play an important role to reduce alcohol use and smoking at the same time. Unexpectedly, nicotine replacement therapy performed as well as the prescription drugs varenicline and cytisine.

8 Aug 2022

HIV/AIDS News and Research

Further Reading

Did telehealth appointments improve HIV care retention during the COVID-19 pandemic?

Gut microbiome could contribute to a person's risk for HIV infection, research suggests

Gut microbiome likely to contribute to HIV infection

Court ruling may spur competitive health plans to bring back copays for preventive services

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Potential HIV vaccine component leads to strong protection in primates

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

NIH experts discuss a published case series detailing the symptoms and outcomes of monkeypox

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

A needle exchange project modeled on urban efforts aims to save lives in rural Nevada

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

To stem the spread of monkeypox, health departments tap into networks of those most at risk

Study finds significant evidence for inaccurate and misleading labeling of CBD content

Alcohol consumption does not provide any health benefits, presents many risks for young people

Researchers receive $3.25 million NIH grant to better understand the oral manifestations of HIV

People living in South Asia could lose about five years of life expectancy to air pollution

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News